Deflazacort: A Lifeline in Duchenne Muscular Dystrophy

Duchenne Muscular Dystrophy (DMD) devastates muscles. This condition requires urgent intervention. Recent advancements in treatment options offer hope. One such option is deflazacort. This corticosteroid addresses symptoms effectively. This article explores its impact and connections to other medical areas.

Deflazacort in Duchenne Muscular Dystrophy

DMD afflicts young boys primarily. The disease is progressive and debilitating. Generic viagra pill identifier aids in distinguishing legitimate sildenafil tablets, preventing errors. When considering the maximum dose of sildenafil per day, consult medical guidelines. Evaluating a viagra sample can offer insight into its efficacy. Deflazacort modifies disease progression. It decreases inflammation and muscle damage. Patients exhibit improved muscle strength and function. This drug helps extend ambulation time significantly.

Long-term use of deflazacort shows varied outcomes. Weight gain and growth delays pose challenges. Physicians must monitor these side effects. Balancing benefits and risks becomes essential in treatment protocols. Continuous research aims to refine its application in DMD management.

Ioversol and Diagnostic Imaging

Effective disease management relies on accurate diagnosis. Ioversol enhances diagnostic imaging precision. This contrast agent improves visibility in scans. Enhanced imaging aids in assessing disease severity. Clearer images inform treatment decisions.

Combination of deflazacort with ioversol-enhanced imaging refines DMD treatment strategies. Detailed scans reveal more about muscular deterioration. Physicians tailor interventions accordingly. This synergy represents a significant advance in personalized medicine.

Hand Surgery: A Complementary Approach

Advanced stages of DMD affect hand function. Muscles weaken and contractures develop. Hand surgery offers a surgical remedy. Surgeons release contractures to restore some function. This intervention improves quality of life in severe cases.

Surgical strategies complement deflazacort therapy. Together, they mitigate functional decline. This multidisciplinary approach enhances patient outcomes. Both methods aim to preserve independence as long as possible.

Stroke Risk and DMD

Research highlights an unexpected risk in DMD patients. Stroke incidence appears elevated. Circulatory issues may contribute. Physicians must remain vigilant for early signs. Prompt management can prevent serious consequences.

Deflazacort may play a protective role. Its anti-inflammatory properties might reduce stroke risk. This potential warrants further study. Understanding the connection remains critical for comprehensive care strategies.

Genetics and Future Perspectives

DMD roots lie in genetic mutations. Ongoing research investigates gene therapy possibilities. This avenue promises groundbreaking developments. Genetic understanding shapes future interventions.

Deflazacort continues as a cornerstone treatment. New genetic insights may optimize its use. Researchers explore synergies between corticosteroids and gene therapy. Such combinations could revolutionize care for DMD patients.

Comprehensive strategies offer hope. They extend quality and duration of life. Future breakthroughs hinge on genetic advancements and therapeutic integration.

Conclusion

Deflazacort represents a vital component in managing DMD. Its integration with imaging, surgery, and genetic insights improves outcomes. Each advancement adds a layer of hope for affected families. The multifaceted approach continues to evolve. What age does a man stop getting a hard on is a common query, yet erectile function varies greatly among individuals. Factors like health and lifestyle influence this, and an ED specialist near me can offer insights. For more information, visit Meadowbrookfamilydentists.com/ Ongoing research drives further progress in this relentless battle.

Data source:

Silvitra: Versatile and Cautious Use

Feature Details
Brand Name Silvitra
Active Ingredients Sildenafil 100 mg, Vardenafil 20 mg
Usage Treats erectile dysfunction
Form Tablet
Manufacturer Generic
Learn More About Silvitra

Other Uses for Silvitra

While Silvitra is primarily used for erectile dysfunction, it also holds potential in other areas. Researchers are examining its impact on pulmonary arterial hypertension. This is due to sildenafil’s known effects on blood vessels. Vardenafil, combined with sildenafil in Silvitra, enhances its scope. This dual-action tablet could potentially address other circulatory issues. Such applications remain experimental but show promise.

In the realm of sexual health, Silvitra’s role extends beyond erectile dysfunction. Some healthcare professionals consider it for conditions like premature ejaculation. This is based on its ability to regulate blood flow and improve performance. Silvitra offers a dual benefit for individuals seeking comprehensive solutions. Although not universally approved for these uses, discussions continue. Always consult a physician before attempting alternative treatments.

The blending of sildenafil 100 mg and vardenafil 20 mg distinguishes Silvitra. These substances, while similar, target different enzymes. Together, they offer a unique therapeutic profile. This makes Silvitra a candidate for off-label discussions. Such exploration requires clinical oversight. The blend may pave the way for new approaches in men’s health.

Warning & Precautions

Using Silvitra demands careful consideration of warnings and precautions. Patients should disclose all medical history to their doctors. This includes any heart, liver, or kidney problems. Drug interactions are critical, particularly with nitrates. Combining these can lead to dangerous blood pressure drops.

Potential side effects of Silvitra are varied. Common ones include headaches, flushing, or dizziness. Severe reactions may involve vision changes or priapism. Such instances require immediate medical attention. Regular monitoring by healthcare professionals is advised.

Special caution is necessary for those with allergies to sildenafil or vardenafil. Discuss any adverse reactions with a healthcare provider. Alcohol consumption should be moderated to avoid increased side effects. Elderly patients might need adjusted dosages. A comprehensive assessment helps prevent complications.

Silvitra Disposal

Proper disposal of Silvitra is essential to avoid misuse. Unused or expired tablets should not be discarded in household waste. They could pose risks to others or the environment. Pharmaceutical waste guidelines suggest returning them to pharmacies. This ensures safe and environmentally responsible disposal.

Never flush Silvitra down the toilet. Water contamination and wildlife harm can result. If pharmacy return options are unavailable, consult local waste management authorities. They can provide guidance on safe disposal practices.

Storing Silvitra appropriately extends its shelf life. Keep it in a cool, dry place, away from children and pets. Proper storage helps maintain potency and effectiveness. It also prevents accidental ingestion by unintended users.

Toxicity

Understanding the toxicity of Silvitra is paramount. Overdose or misuse can lead to severe outcomes. High doses might cause cardiovascular stress. Symptoms could include chest pain or irregular heartbeat. In such cases, immediate medical intervention is vital.

Research on Silvitra’s toxicology highlights the importance of dosage adherence. The blend of sildenafil and vardenafil requires precision. Toxicity studies suggest close monitoring during treatment. Patients should follow prescribed amounts strictly.

Interactions with other medications can amplify toxic risks. Particularly, mixing with blood pressure-lowering drugs. Inform healthcare providers of all current medications. Regular follow-up appointments can catch potential toxicity early. Patients should report any unusual symptoms promptly.

Silvitra Over the Counter

Acquiring Silvitra over the counter presents challenges. Its active ingredients, sildenafil and vardenafil, are prescription-only in many regions. This ensures appropriate use under medical supervision. Some online sources may claim to sell it without prescriptions. Such purchases risk acquiring counterfeit or unsafe products.

Prescription regulations vary by country. In some areas, licensed pharmacists can provide it after a consultation. Always prioritize buying from reputable sources. Verifying the authenticity of the supplier is crucial.

The necessity for a prescription serves multiple purposes. It helps tailor the treatment to individual needs and monitors side effects. A healthcare provider ensures that Silvitra is suitable for the patient. Compliance with these guidelines ensures safety and effectiveness.

Key Points to Remember

  • Silvitra combines sildenafil 100 mg and vardenafil 20 mg.
  • Primary use: erectile dysfunction.
  • Potential in treating pulmonary arterial hypertension.
  • Strict adherence to dosage is crucial.
  • Prescription-only in many regions.

Information taken from:

āĻāĻ•āĻŸāĻŋ āĻ…āĻ¨āĻŋāĻļā§āĻšāĻŋāĻ¤ āĻ¯āĻžāĻ¤ā§āĻ°āĻž

āĻĨā§‡āĻ•ā§‡ āĻĨā§‡āĻ•ā§‡ āĻ˜ā§āĻŽ āĻ­ā§‡āĻ™ā§āĻ—ā§‡ āĻ¯āĻžāĻ¯āĻŧāĨ¤ āĻ¯āĻ¤āĻ•ā§āĻˇāĻŖ āĻ˜ā§āĻŽāĻžāĻ‡, āĻĻā§āĻƒāĻ¸ā§āĻŦāĻĒā§āĻ¨ āĻ›āĻžāĻĄāĻŧāĻž āĻ•āĻŋāĻ›ā§āĻ‡ āĻĻā§‡āĻ–āĻŋāĻ¨āĻžāĨ¤ āĻ¸āĻžāĻ°āĻžāĻĻāĻŋāĻ¨ āĻ…āĻ¸ā§āĻĨāĻŋāĻ°āĻ¤āĻžāĻ° āĻŽāĻ§ā§āĻ¯ā§‡ āĻĨāĻžāĻ•āĻŋāĨ¤ āĻ•ā§‹āĻ¨ā§‹ āĻ•āĻžāĻœā§‡ āĻŽāĻ¨ āĻŦāĻ¸ā§‡ āĻ¨āĻžāĨ¤ āĻ†āĻŦāĻžāĻ° āĻŦāĻ¸ā§‡āĻ“ āĻĨāĻžāĻ•āĻž āĻ¯āĻžāĻ¯āĻŧ āĻ¨āĻžāĨ¤ āĻ¸āĻŦ āĻŽāĻŋāĻ˛āĻŋāĻ¯āĻŧā§‡ āĻŦāĻŋāĻļā§āĻ°ā§€-āĻ˜ā§‹āĻ˛āĻžāĻŸā§‡ āĻāĻ•āĻŸāĻž āĻ…āĻŦāĻ¸ā§āĻĨāĻžāĨ¤ āĻāĻ‡ āĻ…āĻŦāĻ¸ā§āĻĨāĻž āĻ†āĻŽāĻžāĻ° āĻāĻ•āĻžāĻ° āĻ¨āĻ¯āĻŧāĨ¤ āĻ¯āĻžāĻĻā§‡āĻ° āĻ¸āĻžāĻĨā§‡āĻ‡ āĻ†āĻŽāĻžāĻ° āĻ•āĻĨāĻž āĻšāĻ¯āĻŧ, āĻ¸āĻŦāĻžāĻ°āĻ‡ āĻāĻ•āĻ‡ āĻĒāĻ°āĻŋāĻ¸ā§āĻĨāĻŋāĻ¤āĻŋāĨ¤ āĻ•ā§‡āĻ‰āĻ‡ āĻ­āĻžāĻ˛ āĻ¨ā§‡āĻ‡āĨ¤ āĻĨāĻžāĻ•āĻŦā§‡āĻ‡ āĻŦāĻž āĻ•āĻŋāĻ­āĻžāĻŦā§‡? āĻ—ā§‹āĻŸāĻž āĻĻā§‡āĻļāĻŸāĻžāĻ‡ āĻāĻ•āĻŸāĻž āĻ°āĻ•ā§āĻ¤āĻ¸ā§āĻ¨āĻžāĻ¤ āĻŦāĻŋāĻĒā§āĻ˛āĻŦā§‡āĻ° āĻŽāĻ§ā§āĻ¯ āĻĻāĻŋāĻ¯āĻŧā§‡ āĻ¯āĻžāĻšā§āĻ›ā§‡āĨ¤ āĻ•āĻŋ āĻ¸āĻžāĻ§āĻžāĻ°āĻ¨ āĻāĻ•āĻŸāĻž āĻ†āĻ¨ā§āĻĻā§‹āĻ˛āĻ¨ āĻ•āĻ°āĻ›āĻŋāĻ˛ āĻŦāĻŋāĻļā§āĻŦāĻŦāĻŋāĻĻā§āĻ¯āĻžāĻ˛āĻ¯āĻŧā§‡āĻ° āĻ›āĻžāĻ¤ā§āĻ°āĻ›āĻžāĻ¤ā§āĻ°ā§€āĻ°āĻžāĨ¤ āĻāĻ•āĻŸāĻžāĻ‡ āĻĻāĻžāĻŦāĻŋ – āĻ•ā§‹āĻŸāĻž āĻĒāĻĻā§āĻ§āĻ¤āĻŋāĻ° āĻ¸āĻ‚āĻ¸ā§āĻ•āĻžāĻ° āĻšāĻžāĻ¯āĻŧāĨ¤ āĻ•āĻŋāĻ¨ā§āĻ¤ā§ āĻ¤āĻž āĻ†āĻ° āĻšāĻ¤ā§‡ āĻĻāĻŋāĻ˛ āĻ•āĻ‡? āĻ›āĻžāĻ¤ā§āĻ°āĻ›āĻžāĻ¤ā§āĻ°ā§€āĻĻā§‡āĻ° āĻšā§‡āĻ¯āĻŧ āĻ•āĻ°ā§‡ āĻĒā§āĻ°āĻ§āĻžāĻ¨āĻŽāĻ¨ā§āĻ¤ā§āĻ°ā§€ āĻ¸āĻš āĻ…āĻ¨ā§‡āĻ• āĻŽāĻ¨ā§āĻ¤ā§āĻ°ā§€āĻĻā§‡āĻ° āĻ˛āĻžāĻ—āĻžāĻŽāĻšā§€āĻ¨ āĻŽā§āĻ–ā§‡āĻ° āĻŦā§āĻ˛āĻŋ āĻĒāĻ°āĻŋāĻ¸ā§āĻĨāĻŋāĻ¤āĻŋ āĻ‰āĻĨāĻžāĻ˛ āĻ•āĻ°ā§‡ āĻ¤ā§āĻ˛ā§‡āĨ¤ āĻ¸āĻ°āĻ•āĻžāĻ° āĻĒā§āĻ°āĻĨāĻŽā§‡ āĻ›āĻžāĻ¤ā§āĻ°āĻ˛ā§€āĻ—āĻ•ā§‡ āĻ˛ā§‡āĻ˛āĻŋāĻ¯āĻŧā§‡ āĻĻāĻŋāĻ¯āĻŧā§‡, āĻĒāĻ°ā§‡ āĻĒā§āĻ˛āĻŋāĻļ āĻĻāĻŋāĻ¯āĻŧā§‡, āĻāĻŦāĻ‚ āĻļā§‡āĻˇ āĻĒāĻ°ā§āĻ¯āĻ¨ā§āĻ¤ āĻ¨āĻž āĻĒā§‡āĻ°ā§‡ āĻŦāĻŋāĻœāĻŋāĻŦāĻŋ-āĻ†āĻ°ā§āĻŽāĻŋ āĻ¨āĻžāĻŽāĻŋāĻ¯āĻŧā§‡ āĻ†āĻ¨ā§āĻĻā§‹āĻ˛āĻ¨ āĻ ā§‡āĻ•āĻžāĻ¨ā§‹āĻ° āĻŦā§āĻ¯āĻ°ā§āĻĨ āĻšā§‡āĻˇā§āĻŸāĻž āĻāĻ–āĻ¨āĻ“ āĻ•āĻ°ā§‡ āĻšāĻ˛āĻ›ā§‡āĨ¤Â 

‘āĻĻā§‡āĻ–āĻžāĻŽāĻžāĻ¤ā§āĻ° āĻ—ā§āĻ˛āĻŋ’ āĻ•āĻ°āĻžāĻ° āĻāĻ‡ āĻŦāĻ°ā§āĻŦāĻ°āĻ¤āĻž āĻĨā§‡āĻ•ā§‡ āĻ›ā§‹āĻŸ-āĻŦāĻĄāĻŧ, āĻ›āĻžāĻ¤ā§āĻ°-āĻ…āĻ›āĻžāĻ¤ā§āĻ° āĻ•ā§‡āĻ‰ āĻ°ā§‡āĻšāĻžāĻ‡ āĻĒāĻžāĻ¯āĻŧāĻ¨āĻŋāĨ¤ āĻšā§‹āĻ• āĻ¸ā§‡āĻŸāĻž āĻ…āĻ¸ā§€āĻŽ āĻ¸āĻžāĻšāĻ¸āĻŋāĻ•āĻ¤āĻžāĻ¯āĻŧ āĻ…āĻ¸ā§āĻ¤ā§āĻ°ā§‡āĻ° āĻŽā§āĻ–ā§‡ āĻŦā§āĻ• āĻĒā§‡āĻ¤ā§‡ āĻļāĻšā§€āĻĻ āĻšāĻ“āĻ¯āĻŧāĻž āĻ†āĻŦā§ āĻ¸āĻžāĻˆāĻĻ, āĻ…āĻĨāĻŦāĻž āĻŦāĻžāĻŦāĻžāĻ° āĻ¸āĻžāĻĨā§‡ āĻŦāĻŋāĻ•āĻžāĻ˛ā§‡ āĻ–ā§‡āĻ˛āĻ¤ā§‡ āĻ—āĻŋāĻ¯āĻŧā§‡ āĻ—ā§āĻ˛āĻŋ āĻ–āĻžāĻ“āĻ¯āĻŧāĻž āĻ›ā§‹āĻŸā§āĻŸ āĻļāĻŋāĻļā§ āĻ°āĻŋāĻ¯āĻŧāĻž āĻŦāĻž āĻ¯ā§ŒāĻ•ā§āĻ¤āĻŋāĻ• āĻ†āĻ¨ā§āĻĻā§‹āĻ˛āĻ¨ā§‡ āĻŦāĻ¨ā§āĻ§ā§āĻĻā§‡āĻ° āĻĒāĻžāĻ¨āĻŋ āĻŦāĻŋāĻ˛āĻŋāĻ¯āĻŧā§‡ āĻŦā§‡āĻĄāĻŧāĻžāĻ¨ā§‹ āĻŽā§āĻ—ā§āĻ§ – āĻ¸āĻžāĻŽāĻžāĻœāĻŋāĻ• āĻ¯ā§‹āĻ—āĻžāĻ¯ā§‹āĻ— āĻŽāĻžāĻ§ā§āĻ¯āĻŽā§‡āĻ° āĻ•āĻ˛ā§āĻ¯āĻžāĻŖā§‡ āĻĻā§‡āĻļā§‡āĻ° āĻĒā§āĻ°āĻ¤āĻŋāĻŸāĻž āĻ˜āĻ°ā§‡ āĻ‰āĻ¤ā§āĻ¤āĻžāĻĒ āĻ›āĻĄāĻŧāĻŋāĻ¯āĻŧā§‡ āĻĒāĻĄāĻŧā§‡āĨ¤ āĻ§ā§€āĻ°ā§‡ āĻ§ā§€āĻ°ā§‡ āĻļā§āĻ§ā§āĻŽāĻžāĻ¤ā§āĻ° āĻ›āĻžāĻ¤ā§āĻ° āĻ›āĻžāĻ¤ā§āĻ°ā§€āĻĻā§‡āĻ° āĻ†āĻ¨ā§āĻĻā§‹āĻ˛āĻ¨ āĻĨā§‡āĻ•ā§‡ āĻāĻ‡ āĻ†āĻ¨ā§āĻĻā§‹āĻ˛āĻ¨ āĻœāĻ¨āĻ¸āĻžāĻ§āĻžāĻ°āĻŖā§‡āĻ° āĻ†āĻ¨ā§āĻĻā§‹āĻ˛āĻ¨ā§‡ āĻ°ā§‚āĻĒ āĻ¨ā§‡āĻ¯āĻŧāĨ¤ āĻ†āĻ¨ā§āĻĻā§‹āĻ˛āĻ¨ā§‡ āĻ¯ā§‹āĻ— āĻĻāĻŋāĻ¤ā§‡ āĻļā§āĻ°ā§ āĻ•āĻ°ā§‡āĻ¨ āĻŦāĻžāĻŦāĻžāĻŽāĻž, āĻļāĻŋāĻ•ā§āĻˇāĻ•āĻļāĻŋāĻ•ā§āĻˇāĻŋāĻ•āĻž āĻĨā§‡āĻ•ā§‡ āĻļā§āĻ°āĻŽāĻœā§€āĻŦā§€āĻ°āĻž āĻĒāĻ°ā§āĻ¯āĻ¨ā§āĻ¤āĨ¤ āĻ¸āĻ°āĻ•āĻžāĻ° āĻ­ā§‡āĻŦā§‡āĻ›āĻŋāĻ˛ āĻ—ā§āĻ˛āĻŋ āĻ•āĻ°āĻ˛ā§‡ āĻ›āĻžāĻ¤ā§āĻ°āĻ›āĻžāĻ¤ā§āĻ°ā§€āĻ°āĻž āĻ­āĻ¯āĻŧā§‡ āĻĒāĻžāĻ˛āĻžāĻŦā§‡āĨ¤ āĻ¤āĻžāĻ°āĻž āĻœāĻžāĻ¨āĻ¤ āĻ¨āĻž, āĻāĻ• āĻ†āĻŦā§ āĻ¸āĻžāĻˆāĻĻāĻ•ā§‡ āĻŽāĻžāĻ°āĻ˛ā§‡ āĻšāĻžāĻœāĻžāĻ°ā§‹ āĻ†āĻŦā§ āĻ¸āĻžāĻˆāĻĻ āĻŦāĻ¨ā§āĻĻā§āĻ•ā§‡āĻ° āĻŽā§āĻ–ā§‡ āĻŦā§āĻ• āĻĒā§‡āĻ¤ā§‡ āĻšāĻžāĻ¸āĻ¤ā§‡ āĻšāĻžāĻ¸āĻ¤ā§‡ āĻĒā§āĻ°āĻžāĻŖ āĻĻāĻŋāĻŦā§‡āĨ¤ āĻ¤āĻžāĻ°āĻž āĻœāĻžāĻ¨āĻ¤ā§‹ āĻ¨āĻž, āĻāĻ• āĻŽā§āĻ—ā§āĻ§āĻ•ā§‡ āĻŽāĻžāĻ°āĻ˛ā§‡ āĻšāĻžāĻœāĻžāĻ° āĻŽā§āĻ—ā§āĻ§ āĻāĻ¸ā§‡ āĻĒāĻžāĻ¨āĻŋ āĻŦāĻŋāĻ˛āĻŋāĻ¯āĻŧā§‡ āĻ¯āĻžāĻŦā§‡āĨ¤ āĻ¤āĻžāĻ°āĻž āĻœāĻžāĻ¨āĻ¤ āĻ¨āĻž āĻ°āĻ•ā§āĻ¤ āĻ¸āĻžāĻšāĻ¸āĻ•ā§‡ āĻšāĻžāĻœāĻžāĻ°āĻ—ā§āĻ¨ā§‡ āĻŦāĻžāĻĄāĻŧāĻŋāĻ¯āĻŧā§‡ āĻ¤ā§āĻ˛āĻŦā§‡āĨ¤ āĻŦāĻšā§ āĻ¨āĻžāĻŸāĻ•ā§€āĻ¯āĻŧāĻ¤āĻžāĻ° āĻŽāĻ§ā§āĻ¯ āĻĻāĻŋāĻ¯āĻŧā§‡ āĻ‡āĻ¨ā§āĻŸāĻžāĻ°āĻ¨ā§‡āĻŸ āĻŦāĻ¨ā§āĻ§ āĻ•āĻ°ā§‡āĻ“ āĻ¸ā§āĻŦāĻŋāĻ§āĻž āĻ•āĻ°āĻ¤ā§‡ āĻĒāĻžāĻ°ā§‡āĻ¨āĻŋ āĻ¸āĻ°āĻ•āĻžāĻ°āĨ¤ āĻ āĻŋāĻ• āĻ¯ā§‡āĻ¨ āĻāĻ•āĻžāĻ¤ā§āĻ¤āĻ°ā§‡āĻ° āĻŽāĻ¤ āĻŦāĻŋāĻĻā§‡āĻļāĻŋ āĻŽāĻŋāĻĄāĻŋāĻ¯āĻŧāĻžāĻ° āĻ•āĻ˛ā§āĻ¯āĻžāĻŖā§‡ āĻāĻ‡ āĻ¨ā§ˆāĻ°āĻžāĻœā§āĻ¯ā§‡āĻ° āĻ–āĻŦāĻ° āĻĻā§āĻ¨āĻŋāĻ¯āĻŧāĻžāĻ¯āĻŧ āĻ›āĻĄāĻŧāĻŋāĻ¯āĻŧā§‡ āĻĒāĻĄāĻŧā§‡āĨ¤ āĻĻā§āĻ¨āĻŋāĻ¯āĻŧāĻžāĻ° āĻ¨āĻžāĻ¨āĻžāĻ¨ āĻĒā§āĻ°āĻžāĻ¨ā§āĻ¤ā§‡ āĻĨāĻžāĻ•āĻž āĻŦāĻžāĻ™ā§āĻ—āĻžāĻ˛āĻŋ āĻ›āĻžāĻ¤ā§āĻ°āĻ›āĻžāĻ¤ā§āĻ°ā§€āĻ°āĻž āĻĒā§āĻ°āĻ¤āĻŋāĻŦāĻžāĻĻ āĻ—āĻĄāĻŧā§‡ āĻ¤ā§āĻ˛ā§‡āĨ¤ āĻ…āĻŦāĻļā§‡āĻˇā§‡ āĻ¸āĻ°āĻ•āĻžāĻ° āĻšāĻžāĻ‡āĻ•ā§‹āĻ°ā§āĻŸā§‡āĻ° āĻ†āĻĒāĻŋāĻ˛ āĻŦāĻŋāĻ­āĻžāĻ—ā§‡āĻ° āĻ°āĻžāĻ¯āĻŧ āĻāĻ—āĻŋāĻ¯āĻŧā§‡ āĻāĻ¨ā§‡ āĻ•ā§‹āĻŸāĻž āĻĒāĻĻā§āĻ§āĻ¤āĻŋāĻ° āĻ¸āĻ‚āĻ¸ā§āĻ•āĻžāĻ° āĻ•āĻ°ā§‡āĨ¤ āĻ•āĻŋāĻ¨ā§āĻ¤ā§ āĻ¤āĻ¤āĻĻāĻŋāĻ¨ā§‡ āĻ…āĻ¨ā§‡āĻ• āĻĒāĻžāĻ¨āĻŋ āĻ—āĻĄāĻŧāĻŋāĻ¯āĻŧā§‡āĻ›ā§‡āĨ¤ āĻ¸āĻžāĻ°āĻžāĻĻā§‡āĻļā§‡ āĻŦāĻ¯āĻŧā§‡ āĻ—ā§‡āĻ›ā§‡ āĻ°āĻ•ā§āĻ¤ āĻ—āĻ™ā§āĻ—āĻžāĨ¤ āĻāĻŸāĻž āĻ†āĻ° āĻ•ā§‹āĻŸāĻž āĻ¸āĻ‚āĻ¸ā§āĻ•āĻžāĻ° āĻ†āĻ¨ā§āĻĻā§‹āĻ˛āĻ¨ āĻ¨ā§‡āĻ‡āĨ¤ āĻšāĻ¯āĻŧā§‡ āĻ—ā§‡āĻ›ā§‡ āĻ°āĻžāĻˇā§āĻŸā§āĻ° āĻ¸āĻ‚āĻ¸ā§āĻ•āĻžāĻ° āĻ†āĻ¨ā§āĻĻā§‹āĻ˛āĻ¨āĨ¤ āĻāĻ° āĻŽāĻ§ā§āĻ¯ā§‡ āĻ¸āĻ°āĻ•āĻžāĻ°ā§€ āĻĒā§‹āĻˇāĻž āĻŦā§āĻĻā§āĻ§āĻŋāĻœā§€āĻŦā§€āĻĻā§‡āĻ° āĻ¸ā§āĻŦāĻžāĻ•ā§āĻˇāĻ°āĻŋāĻ¤ āĻŦāĻŋāĻŦā§ƒāĻ¤āĻŋ āĻĻāĻŋāĻ¯āĻŧā§‡ āĻŦāĻž āĻ—āĻŖāĻŽāĻžāĻ§ā§āĻ¯āĻŽā§‡āĻ° āĻ¨āĻŋāĻ¯āĻŧāĻ¨ā§āĻ¤ā§āĻ°āĻŖ āĻ¨āĻŋāĻ¯āĻŧā§‡, āĻŦāĻž āĻœāĻžāĻŽāĻžāĻ¤-āĻļāĻŋāĻŦāĻŋāĻ°-āĻŦāĻŋāĻāĻ¨āĻĒāĻŋāĻ° āĻ‰āĻĒāĻ° āĻĻāĻžāĻ¯āĻŧ āĻšāĻžāĻĒāĻŋāĻ¯āĻŧā§‡ āĻ†āĻ¨ā§āĻĻā§‹āĻ˛āĻ¨ āĻ­āĻŋāĻ¨ā§āĻ¨ āĻ–āĻžāĻ¤ā§‡ āĻĒā§āĻ°āĻŦāĻžāĻšāĻŋāĻ¤ āĻ•āĻ°āĻžāĻ° āĻ…āĻ¨ā§‡āĻ• āĻĒā§āĻ°āĻšā§‡āĻˇā§āĻŸāĻž āĻšāĻ¯āĻŧā§‡āĻ›ā§‡āĨ¤ āĻ›āĻžāĻ¤ā§āĻ°āĻ›āĻžāĻ¤ā§āĻ°ā§€āĻ°āĻž āĻ¸ā§‡āĻŸāĻž āĻšāĻ¤ā§‡ āĻĻā§‡āĻ¯āĻŧāĻ¨āĻŋāĨ¤ āĻ¤āĻžāĻ°āĻž āĻ¸āĻĢāĻ˛āĨ¤ āĻāĻ–āĻ¨āĻ“ āĻ†āĻ¨ā§āĻĻā§‹āĻ˛āĻ¨ āĻšāĻ˛āĻ›ā§‡ āĻ¸āĻžāĻ°āĻžāĻĻā§‡āĻļā§‡āĨ¤Â 

āĻļā§āĻ°ā§ āĻĨā§‡āĻ•ā§‡āĻ‡ āĻ¸āĻ°āĻ•āĻžāĻ°ā§‡āĻ° āĻŽāĻ§ā§āĻ¯ā§‡ āĻāĻ‡ āĻ†āĻ¨ā§āĻĻā§‹āĻ˛āĻ¨ā§‡ āĻœāĻĄāĻŧāĻŋāĻ¤ āĻ›āĻžāĻ¤ā§āĻ°āĻ›āĻžāĻ¤ā§āĻ°ā§€āĻĻā§‡āĻ° āĻšā§‡āĻ¯āĻŧ āĻ•āĻ°ā§‡ āĻ•āĻĨāĻž āĻŦāĻ˛āĻ¤ā§‡ āĻĻā§‡āĻ–āĻž āĻ¯āĻžāĻ¯āĻŧāĨ¤ āĻ†āĻ¨ā§āĻ¤āĻ°āĻŋāĻ•āĻ¤āĻžāĻ° āĻ˜āĻžāĻŸāĻ¤āĻŋ āĻĻā§‡āĻ–āĻž āĻ¯āĻžāĻ¯āĻŧāĨ¤ āĻ¸āĻ°āĻ•āĻžāĻ° āĻ­ā§āĻ˛ā§‡ āĻ—āĻŋāĻ¯āĻŧā§‡āĻ›āĻŋāĻ˛ā§‡āĻ¨ āĻ¯ā§‡ āĻ¤āĻžāĻ°āĻž āĻĻāĻ¯āĻŧāĻžāĻ° āĻœāĻ¨ā§āĻ¯ āĻ†āĻ¸ā§‡āĻ¨āĻŋāĨ¤ āĻŦāĻ°āĻ‚ āĻāĻŸāĻž āĻāĻ•āĻŸāĻž āĻ…āĻ§āĻŋāĻ•āĻžāĻ° āĻ†āĻĻāĻžāĻ¯āĻŧā§‡āĻ° āĻ†āĻ¨ā§āĻĻā§‹āĻ˛āĻ¨āĨ¤ āĻ¸āĻ•āĻ˛ āĻ­ā§āĻ˛ āĻŦā§āĻāĻžāĻŦā§āĻāĻŋāĻ° āĻļā§āĻ°ā§ āĻāĻ‡ āĻāĻ•āĻŸāĻž āĻœāĻžāĻ¯āĻŧāĻ—āĻž āĻĨā§‡āĻ•ā§‡āĻ‡āĨ¤ āĻ¸āĻ°āĻ•āĻžāĻ° āĻ†āĻ¨ā§āĻ¤āĻ°āĻŋāĻ• āĻšāĻ¤ā§‡ āĻĒāĻžāĻ°āĻ¤ā§‡āĻ¨āĨ¤ āĻ¯ā§‡āĻ­āĻžāĻŦā§‡ āĻ¸āĻ°āĻ•āĻžāĻ°āĻŋ āĻŦāĻžāĻšāĻŋāĻ¨ā§€ āĻ›āĻžāĻ¤ā§āĻ° āĻ›āĻžāĻ¤ā§āĻ°ā§€āĻĻā§‡āĻ° āĻĻāĻŋāĻ•ā§‡ āĻ—ā§āĻ˛āĻŋ āĻ›ā§āĻĄāĻŧā§‡āĻ›ā§‡, āĻ¸āĻžāĻāĻœā§‹āĻ¯āĻŧāĻž āĻ¯āĻžāĻ¨ āĻ¨āĻžāĻŽāĻŋāĻ¯āĻŧā§‡āĻ›ā§‡, āĻšā§‡āĻ˛āĻŋāĻ•āĻĒā§āĻŸāĻžāĻ° āĻ‰āĻĄāĻŧāĻŋāĻ¯āĻŧā§‡āĻ›ā§‡ – āĻĻā§‡āĻ–ā§‡ āĻ¤ā§‹ āĻŽāĻ¨ā§‡ āĻšāĻ¯āĻŧ āĻ­āĻŋāĻ¨āĻĻā§‡āĻļāĻŋ āĻļāĻ¤ā§āĻ°ā§ āĻĻā§‡āĻļ āĻĻāĻ–āĻ˛ā§‡āĻ° āĻœāĻ¨ā§āĻ¯ āĻ†āĻ•ā§āĻ°āĻŽāĻŖ āĻ•āĻ°ā§‡āĻ›ā§‡āĨ¤ āĻ†āĻ° āĻ¤āĻžāĻĻā§‡āĻ° āĻ ā§‡āĻ•āĻžāĻ¨ā§‹āĻ° āĻšā§‡āĻˇā§āĻŸāĻž āĻ•āĻ°āĻ›ā§‡ āĻ¸āĻ°āĻ•āĻžāĻ°āĨ¤ āĻ¨āĻžāĻšāĻ˛ā§‡ āĻ¨āĻŋāĻœā§‡āĻ° āĻĻā§‡āĻļā§‡āĻ° āĻ›āĻžāĻ¤ā§āĻ°āĻĻā§‡āĻ° āĻŦā§āĻ•ā§‡, āĻ¸āĻžāĻ§āĻžāĻ°āĻŖ āĻœāĻ¨āĻ—āĻŖā§‡āĻ° āĻĻā§‡āĻ¯āĻŧāĻž āĻŸā§āĻ¯āĻžāĻ•ā§āĻ¸ā§‡āĻ° āĻŸāĻžāĻ•āĻžāĻ¯āĻŧ āĻ•ā§‡āĻ¨āĻž āĻ—ā§āĻ˛āĻŋ āĻĻāĻŋāĻ¯āĻŧā§‡ āĻāĻ­āĻžāĻŦā§‡ āĻ¨āĻŋāĻ°ā§āĻĻāĻ¯āĻŧ āĻšāĻ¯āĻŧā§‡ āĻĒāĻžāĻ–āĻŋāĻ° āĻŽāĻ¤ āĻŽāĻžāĻ¨ā§āĻˇ āĻ–ā§āĻ¨ āĻ•āĻ°āĻ¤ā§‡ āĻĒāĻžāĻ°ā§‡ āĻ•ā§‡āĻ‰? āĻŦāĻ°āĻ‚ āĻ¸āĻ°āĻ•āĻžāĻ°ā§‡āĻ° āĻ‰āĻšāĻŋāĻ¤ āĻ›āĻŋāĻ˛ āĻĒā§āĻ°āĻĨāĻŽ āĻĨā§‡āĻ•ā§‡ āĻĻāĻžāĻ¯āĻŧāĻ¸āĻžāĻ°āĻžāĻ­āĻžāĻŦā§‡ āĻŽāĻ¨ā§āĻ¤āĻŦā§āĻ¯ āĻ¨āĻž āĻ•āĻ°ā§‡, āĻŦā§‡āĻĢāĻžāĻāĻ¸ āĻ•āĻĨāĻžāĻŦāĻžāĻ°ā§āĻ¤āĻž āĻ¨āĻž āĻŦāĻ˛ā§‡, āĻ¤ā§āĻšā§āĻ› āĻ¤āĻžāĻšā§āĻ›āĻŋāĻ˛ā§āĻ¯ā§‡āĻ° āĻšā§‹āĻ–ā§‡ āĻ¨āĻž āĻĻā§‡āĻ–ā§‡ āĻ¤āĻžāĻĻā§‡āĻ° āĻĄā§‡āĻ•ā§‡ āĻāĻ¨ā§‡ āĻ†āĻ˛ā§‹āĻšāĻ¨āĻžāĻ¯āĻŧ āĻŦāĻ¸āĻžāĻ¨ā§‹āĨ¤ āĻ•āĻĨāĻž āĻŦāĻ˛ā§‡ āĻ¸ā§āĻ°āĻžāĻšāĻž āĻ•āĻĨāĻžāĨ¤ āĻ¸āĻ°āĻ•āĻžāĻ° āĻāĻ‡ āĻœāĻžāĻ¯āĻŧāĻ—āĻžāĻ¯āĻŧ āĻŽāĻžāĻ°āĻžāĻ¤ā§āĻŽāĻ• āĻ…āĻĻā§‚āĻ°āĻĻāĻ°ā§āĻļāĻŋāĻ¤āĻžāĻ° āĻĒā§āĻ°āĻŽāĻžāĻŖ āĻĻāĻŋāĻ¯āĻŧā§‡āĻ›ā§‡āĨ¤ āĻ¤āĻžāĻĻā§‡āĻ° āĻŽāĻžāĻĨāĻžāĻ¯āĻŧ āĻ°āĻžāĻ–āĻž āĻĻāĻ°āĻ•āĻžāĻ° āĻ›āĻŋāĻ˛ āĻāĻ‡ āĻĻā§‡āĻļā§‡āĻ° āĻ‡āĻ¤āĻŋāĻšāĻžāĻ¸ā§‡āĻ° āĻŽā§‹āĻĄāĻŧ āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨āĻ•āĻžāĻ°ā§€ āĻ¯ā§āĻ—āĻžāĻ¨ā§āĻ¤āĻ•āĻžāĻ°ā§€ āĻ¸āĻŦ āĻ†āĻ¨ā§āĻĻā§‹āĻ˛āĻ¨ā§‡āĻ° āĻ¨ā§‡āĻ¤ā§ƒāĻ¤ā§āĻŦ āĻĻāĻŋāĻ¯āĻŧā§‡āĻ›ā§‡ āĻ›āĻžāĻ¤ā§āĻ°āĻ›āĻžāĻ¤ā§āĻ°ā§€āĻ°āĻžāĨ¤Â 

āĻĒāĻ°āĻ¸ā§āĻĒāĻ° āĻ¸āĻžāĻ‚āĻ˜āĻ°ā§āĻˇāĻŋāĻ• āĻŦāĻž āĻŽāĻžāĻ¨ā§āĻˇā§‡āĻ° āĻŽāĻ¨ā§‡ āĻĒā§āĻ°āĻļā§āĻ¨ā§‡āĻ° āĻ‰āĻĻā§āĻ°ā§‡āĻ•āĻ•āĻžāĻ°ā§€ āĻ…āĻ¨ā§‡āĻ•āĻ—ā§āĻ˛ā§‹ āĻ•āĻžāĻœ āĻ¸āĻ°āĻ•āĻžāĻ° āĻ•āĻ°ā§‡āĻ›ā§‡ āĻāĻ°āĻ‡ āĻŽāĻ§ā§āĻ¯ā§‡āĨ¤ āĻ¤āĻžāĻ° āĻāĻ•āĻŸāĻž āĻšāĻ˛ā§‹ āĻ›āĻžāĻ¤ā§āĻ°āĻ˛ā§€āĻ— āĻ†āĻ° āĻ›āĻžāĻ¤ā§āĻ°āĻĻā§‡āĻ° āĻŽā§āĻ–ā§‹āĻŽā§āĻ–āĻŋ āĻ•āĻ°ā§‡ āĻĻāĻŋāĻ¯āĻŧā§‡āĻ›ā§‡āĨ¤ āĻ…āĻĨāĻš āĻšāĻžāĻ‡āĻ˛ā§‡ āĻ¸āĻ°āĻ•āĻžāĻ° āĻ›āĻžāĻ¤ā§āĻ°āĻ˛ā§€āĻ—āĻ•ā§‡ āĻ¸āĻžāĻ§āĻžāĻ°āĻŖ āĻ›āĻžāĻ¤ā§āĻ°āĻĻā§‡āĻ° āĻŦāĻ¨ā§āĻ§ā§ āĻ“ āĻ†āĻ¨ā§āĻĻā§‹āĻ˛āĻ¨ā§‡āĻ° āĻĻāĻžāĻŦā§€ āĻ†āĻĻāĻžāĻ¯āĻŧā§‡ āĻ¸āĻŽāĻ¨ā§āĻŦāĻ¯āĻŧāĻ• āĻšāĻŋāĻ¸ā§‡āĻŦā§‡āĻ“ āĻ¤ā§āĻ˛ā§‡ āĻ§āĻ°āĻ¤ā§‡ āĻĒāĻžāĻ°āĻ¤ā§‹āĨ¤ āĻāĻŸāĻž āĻ¸ā§āĻĒāĻˇā§āĻŸāĻ¤āĻ‡ āĻĒā§āĻ°āĻ•āĻžāĻļ āĻ•āĻ°ā§‡ āĻ¸āĻžāĻ§āĻžāĻ°āĻŖ āĻ›āĻžāĻ¤ā§āĻ°āĻ›āĻžāĻ¤ā§āĻ°ā§€ āĻ“ āĻ›āĻžāĻ¤ā§āĻ°āĻ˛ā§€āĻ— āĻāĻ• āĻ¨āĻ¯āĻŧāĨ¤ āĻ›āĻžāĻ¤ā§āĻ°āĻ˛ā§€āĻ—ā§‡āĻ° āĻŽāĻ§ā§āĻ¯ā§‡ āĻ…āĻ¸ā§āĻŦāĻžāĻ­āĻžāĻŦāĻŋāĻ• āĻ•āĻŋāĻ›ā§ āĻ†āĻ›ā§‡āĨ¤ āĻĒā§āĻ°āĻ§āĻžāĻ¨āĻŽāĻ¨ā§āĻ¤ā§āĻ°ā§€ āĻāĻ°āĻŽāĻ§ā§āĻ¯ā§‡ āĻĻā§āĻ‡āĻŦāĻžāĻ° āĻœāĻžāĻ¤āĻŋāĻ° āĻ‰āĻĻā§āĻĻā§‡āĻļā§āĻ¯ā§‡ āĻ­āĻžāĻˇāĻŖ āĻĻāĻŋāĻ¯āĻŧā§‡āĻ›ā§‡āĨ¤ āĻĻā§āĻ‡āĻŦāĻžāĻ°āĻ‡ āĻŽāĻžāĻ¨ā§āĻˇā§‡āĻ° āĻšāĻžāĻ¸āĻŋāĻ° āĻĒāĻžāĻ¤ā§āĻ° āĻšāĻ¯āĻŧā§‡āĻ›ā§‡āĻ¨āĨ¤ āĻ¯āĻŋāĻ¨āĻŋ āĻ¨āĻŋāĻœā§‡ āĻ¸ā§āĻŦāĻœāĻ¨ āĻšāĻžāĻ°āĻŋāĻ¯āĻŧā§‡āĻ›ā§‡āĻ¨, āĻ¸ā§‡āĻ‡ āĻ¤āĻŋāĻ¨āĻŋāĻ‡ āĻ…āĻ¨ā§āĻ¯ā§‡āĻ° āĻ¸ā§āĻŦāĻœāĻ¨ āĻšāĻžāĻ°āĻžāĻ¨ā§‹āĻ° āĻ•āĻžāĻ°āĻŖ āĻšāĻ˛ā§‡āĻ¨āĨ¤ āĻ¤āĻžāĻ‡ āĻ¸ā§āĻŦāĻœāĻ¨ āĻšāĻžāĻ°āĻžāĻ¨ā§‹āĻ° āĻŦā§‡āĻĻāĻ¨āĻžāĻ° āĻ•āĻĨāĻž āĻŦāĻ˛ā§‡ āĻ•āĻžāĻ¨ā§āĻ¨āĻž āĻ•āĻ°ā§‡ āĻĻā§‡āĻ¯āĻŧāĻžāĻ° āĻŦāĻŋāĻˇāĻ¯āĻŧāĻŸāĻž āĻŦā§‹āĻ§āĻšāĻ¯āĻŧ āĻœāĻ¨āĻ—āĻŖ āĻ†āĻ° āĻ—ā§āĻ°āĻšāĻŖ āĻ•āĻ°āĻ›ā§‡ āĻ¨āĻžāĨ¤ āĻ‰āĻĒāĻ°āĻ¨ā§āĻ¤ā§, āĻ†āĻ¨ā§āĻĻā§‹āĻ˛āĻ¨ā§‡āĻ° āĻŽāĻžāĻāĻ–āĻžāĻ¨ā§‡ āĻĻā§āĻˇā§āĻ•ā§ƒāĻ¤āĻŋāĻ•āĻžāĻ°ā§€āĻ°āĻž āĻĻā§‡āĻļā§‡āĻ° āĻ¯ā§‡āĻ¸āĻŦ āĻ—ā§āĻ°ā§āĻ¤ā§āĻŦāĻĒā§‚āĻ°ā§āĻŖ āĻ¸ā§āĻĨāĻžāĻĒāĻ¨āĻžāĻ¯āĻŧ āĻ†āĻ—ā§āĻ¨ āĻĻāĻŋāĻ¯āĻŧā§‡āĻ›ā§‡ āĻ¸ā§‡āĻ¸āĻŦ āĻĻā§‡āĻ–āĻžāĻ° āĻĒāĻ° āĻ‰āĻ¨āĻžāĻ° āĻ•āĻžāĻ¨ā§āĻ¨āĻž āĻĻā§‡āĻ–ā§‡ āĻŽāĻ¨ā§‡ āĻšāĻ¯āĻŧā§‡āĻ›ā§‡ āĻŽāĻžāĻ¨ā§āĻˇā§‡āĻ° āĻĒā§āĻ°āĻžāĻŖā§‡āĻ° āĻšā§‡āĻ¯āĻŧā§‡ āĻ¸ā§āĻĨāĻžāĻĒāĻ¨āĻž āĻŦā§‡āĻļāĻŋ āĻŽā§‚āĻ˛ā§āĻ¯āĻŦāĻžāĻ¨āĨ¤ āĻāĻ›āĻžāĻĄāĻŧāĻžāĻ“ āĻ¸āĻžāĻ°āĻžāĻĻā§‡āĻļā§‡ āĻ†āĻ¨ā§āĻĻā§‹āĻ˛āĻ¨ā§‡āĻ° āĻ¨ā§‡āĻ¤ā§ƒāĻ¤ā§āĻŦā§‡ āĻĨāĻžāĻ•āĻž āĻ¸āĻŽāĻ¨ā§āĻŦāĻ¯āĻŧāĻ•āĻžāĻ°ā§€āĻĻā§‡āĻ° āĻ¤ā§āĻ˛ā§‡ āĻāĻ¨ā§‡ āĻŦāĻžāĻ° āĻŦāĻžāĻ° āĻšāĻ¯āĻŧāĻ°āĻžāĻ¨āĻŋ āĻ•āĻ°āĻžāĻŸāĻž āĻ–ā§āĻŦāĻ‡ āĻ•āĻžāĻāĻšāĻž āĻ•āĻžāĻœ āĻŦāĻ˛ā§‡ āĻŽāĻ¨ā§‡ āĻšāĻ¯āĻŧā§‡āĻ›ā§‡āĨ¤ āĻ¯āĻžāĻĻā§‡āĻ° āĻ¨ā§‡āĻ¤ā§ƒāĻ¤ā§āĻŦā§‡ āĻĻā§‡āĻļā§‡ āĻāĻ¤āĻ•āĻŋāĻ›ā§ āĻ˜āĻŸā§‡ āĻ—ā§‡āĻ˛ā§‹, āĻ¸āĻ°āĻ•āĻžāĻ° āĻ•āĻŋāĻ­āĻžāĻŦā§‡ āĻ­āĻžāĻŦāĻ˛ā§‹ āĻŽā§‡āĻ°ā§‡-āĻ§āĻ°ā§‡ āĻ¤āĻžāĻĻā§‡āĻ° āĻĨāĻžāĻŽāĻžāĻ¨ā§‹ āĻ¯āĻžāĻŦā§‡? āĻ¸ā§‡āĻ‡ āĻ•āĻŦā§‡ āĻ¤āĻžāĻ°āĻž āĻŽā§ƒāĻ¤ā§āĻ¯ā§āĻ° āĻ­āĻ¯āĻŧāĻ•ā§‡ āĻœāĻ¯āĻŧ āĻ•āĻ°ā§‡āĻ›ā§‡ āĻ¤āĻž āĻ¸āĻ°āĻ•āĻžāĻ° āĻ¨āĻŋāĻļā§āĻšāĻ¯āĻŧ āĻœāĻžāĻ¨ā§‡ āĻ¨āĻžāĨ¤ āĻ¤āĻžāĻĻā§‡āĻ° āĻ†āĻ°āĻ“ āĻŦā§āĻāĻžāĻ° āĻĻāĻ°āĻ•āĻžāĻ° āĻ›āĻŋāĻ˛, āĻĻā§‡āĻļā§‡ āĻāĻŽāĻ¨ āĻ†āĻ¨ā§āĻĻā§‹āĻ˛āĻ¨ āĻšāĻ˛ā§‡ āĻœāĻžāĻŽāĻžāĻ¤-āĻļāĻŋāĻŦāĻŋāĻ°-āĻŦāĻŋāĻāĻ¨āĻĒāĻŋ āĻŦāĻ¸ā§‡ āĻĨāĻžāĻ•āĻŦā§‡ āĻ¨āĻžāĨ¤ āĻ¸ā§āĻ¯ā§‹āĻ— āĻ¤āĻžāĻ°āĻž āĻ¨āĻŋāĻŦā§‡āĻ‡āĨ¤Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â 

āĻ¸āĻ°āĻ•āĻžāĻ° āĻ¯āĻ¤ āĻŦā§‡āĻļāĻŋāĻĻāĻŋāĻ¨ āĻ•ā§āĻˇāĻŽāĻ¤āĻžāĻ¯āĻŧ āĻĨāĻžāĻ•āĻŦā§‡, āĻ¤āĻ¤āĻ‡ āĻ¤āĻžāĻ°āĻž āĻœāĻ¨āĻ—āĻŖ āĻĨā§‡āĻ•ā§‡ āĻĻā§‚āĻ°ā§‡ āĻ¸āĻ°ā§‡ āĻ¯āĻžāĻŦā§‡ – āĻāĻŸāĻžāĻ‡ āĻ¸āĻ¤ā§āĻ¯āĨ¤ āĻāĻ‡ ‘āĻĻā§‚āĻ°ā§‡ āĻšāĻ˛ā§‡ āĻ¯āĻžāĻ“āĻ¯āĻŧāĻžāĻ° āĻ¸āĻ°āĻ•āĻžāĻ°āĻ•ā§‡ āĻ…āĻĻā§‚āĻ°āĻĻāĻ°ā§āĻļā§€ āĻ•āĻ°ā§‡ āĻ¤ā§āĻ˛ā§‡āĻ›ā§‡āĨ¤ āĻ†āĻ° āĻāĻ‡ āĻ…āĻĻā§āĻ°āĻĻāĻ°ā§āĻļāĻŋāĻ¤āĻž āĻšāĻžāĻ¸āĻŋāĻ¨āĻž āĻ¸āĻ°āĻ•āĻžāĻ°ā§‡āĻ° āĻœāĻ¨āĻĒā§āĻ°āĻŋāĻ¯āĻŧāĻ¤āĻžāĻ¯āĻŧ āĻ¯ā§‡ āĻ­āĻžāĻŸāĻžāĻ° āĻŸāĻžāĻ¨ āĻĻāĻŋāĻ¯āĻŧā§‡āĻ›ā§‡, āĻ¤āĻž āĻ¤āĻžāĻĻā§‡āĻ° āĻ—āĻĻāĻŋ āĻĨā§‡āĻ•ā§‡ āĻĒāĻ°ā§āĻ¯āĻ¨ā§āĻ¤ āĻ¨āĻžāĻŽāĻŋāĻ¯āĻŧā§‡ āĻĻāĻŋāĻ¤ā§‡ āĻĒāĻžāĻ°ā§‡āĨ¤ āĻāĻ–āĻ¨ āĻŦāĻ°āĻ‚ āĻ–āĻžāĻ˛ āĻ•ā§‡āĻŸā§‡ āĻ•ā§āĻŽāĻŋāĻ° āĻ†āĻ¨āĻ˛ā§‹āĨ¤ āĻ•ā§‡āĻāĻšā§‹ āĻ–ā§āĻĄāĻŧāĻ¤ā§‡ āĻ¸āĻžāĻĒ āĻŦā§‡āĻ°ā§‹āĻ˛ā§‹āĨ¤ āĻāĻ‡ āĻ˜āĻŸāĻ¨āĻž āĻ†āĻ“āĻ¯āĻŧāĻžāĻŽā§€ āĻ˛ā§€āĻ—ā§‡āĻ° āĻ­ā§‡āĻ¤āĻ°ā§‡āĻ“ āĻāĻ• āĻ§āĻ°āĻ¨ā§‡āĻ° āĻ…āĻ¸ā§āĻŦāĻ¸ā§āĻ¤āĻŋ āĻ¤ā§ˆāĻ°āĻŋ āĻ•āĻ°ā§‡āĻ›ā§‡ āĻŦāĻ˛ā§‡ āĻŽāĻ¨ā§‡ āĻšāĻ¯āĻŧāĨ¤ āĻāĻ‡āĻ¤ā§‹ āĻ—āĻ¤āĻ•āĻžāĻ˛ā§‡āĻ° āĻ˜āĻŸāĻ¨āĻž, āĻ†āĻ“āĻ¯āĻŧāĻžāĻŽā§€ āĻ˛ā§€āĻ—ā§‡āĻ° āĻ¸āĻžāĻ§āĻžāĻ°āĻŖ āĻ¸āĻŽā§āĻĒāĻžāĻĻāĻ• āĻ—ā§‡āĻ˛ā§‡āĻ¨ āĻ¤āĻžāĻ° āĻĻāĻ˛ā§‡āĻ° āĻ¸āĻžāĻŦā§‡āĻ• āĻ›āĻžāĻ¤ā§āĻ°āĻ¨ā§‡āĻ¤āĻžāĻĻā§‡āĻ° āĻ¸āĻžāĻĨā§‡ āĻŽāĻ¤āĻŦāĻŋāĻ¨āĻŋāĻŽāĻ¯āĻŧ āĻ•āĻ°āĻ¤ā§‡āĨ¤ āĻ¸ā§‡āĻ–āĻžāĻ¨ā§‡ āĻāĻ• āĻĒāĻ°ā§āĻ¯āĻžāĻ¯āĻŧā§‡ ‘āĻ­ā§āĻāĻ¯āĻŧāĻž-āĻ­ā§āĻāĻ¯āĻŧāĻž’ āĻĻā§āĻ¯āĻŧā§‹āĻ§ā§āĻŦāĻ¨āĻŋāĻ¤ā§‡ āĻ¸āĻŽāĻ¯āĻŧā§‡āĻ° āĻ†āĻ—ā§‡āĻ‡ āĻŦā§‡āĻ° āĻšāĻ¯āĻŧā§‡ āĻ†āĻ¸āĻ¤ā§‡ āĻšāĻ˛ā§‹ āĻ¤āĻžāĻ°āĨ¤ āĻ•ā§āĻˇāĻŽāĻ¤āĻžāĻ¸ā§€āĻ¨ āĻ†āĻ“āĻ¯āĻŧāĻžāĻŽā§€ āĻ˛ā§€āĻ— āĻāĻŦāĻžāĻ° āĻ…āĻ—ā§āĻ¨āĻŋāĻĒāĻ°ā§€āĻ•ā§āĻˇāĻžāĻ° āĻŽā§āĻ–ā§‹āĻŽā§āĻ–āĻŋāĨ¤ āĻœāĻ¨āĻĒā§āĻ°āĻŋāĻ¯āĻŧāĻ¤āĻž, āĻ—āĻŖāĻ¤āĻ¨ā§āĻ¤ā§āĻ°, āĻ•ā§āĻˇāĻŽāĻ¤āĻžāĻ¯āĻŧ āĻŸāĻŋāĻ•ā§‡ āĻĨāĻžāĻ•āĻž, āĻ¸āĻŽā§āĻŽāĻžāĻ¨ – āĻ¸āĻŦāĻ•āĻŋāĻ›ā§āĻ° āĻŽāĻžāĻĒāĻ•āĻžāĻ āĻŋāĻ¤ā§‡ āĻ†āĻ“āĻ¯āĻŧāĻžāĻŽā§€ āĻ˛ā§€āĻ— āĻāĻŦāĻžāĻ° āĻ§āĻ°āĻžāĻļāĻžāĻ¯āĻŧā§€āĨ¤ āĻāĻ–āĻ¨ āĻĻā§‡āĻ–āĻžāĻ° āĻŦāĻŋāĻˇāĻ¯āĻŧ, āĻ•āĻŋ āĻšāĻ¯āĻŧ āĻĻā§‡āĻļā§‡āĻ°āĨ¤ āĻāĻ• āĻ­āĻ¯āĻŧāĻžāĻŦāĻš āĻ…āĻ¨āĻŋāĻļā§āĻšāĻ¯āĻŧāĻ¤āĻžāĻ° āĻŽāĻ§ā§āĻ¯ā§‡ āĻĻāĻŋāĻ¯āĻŧā§‡ āĻ¯āĻžāĻšā§āĻ›ā§‡ āĻ¸ā§āĻŦāĻĻā§‡āĻļāĨ¤Â